title: Male fertility preservation before gonadotoxic therapies.
abstract: BACKGROUND
  Recent advances in cancer therapy have resulted in an increased number of long-term cancer survivors. Unfortunately, aggressive chemotherapy, radiotherapy and preparative regimens for bone marrow transplantation can severely affect male germ cells, including spermatogonial stem cells (SSCs), and lead to permanent loss of fertility. Different options for fertility preservation are dependent on the pubertal state of the patient.
  
  
  METHODS
  Relevant studies were identified by an extensive Medline search of English and French language articles.
  
  
  RESULTS
  Sperm cryopreservation prior to gonadotoxic treatment is a well established method after puberty. In case of ejaculation failure by masturbation, assisted ejaculation methods or testicular tissue sampling should be considered. Although no effective gonadoprotective drug is yet available for in vivo spermatogonial stem cell (SSC) protection in humans, current evidence supports the feasibility of immature testicular tissue (ITT) cryopreservation. The different cryopreservation protocols and available fertility restoration options from frozen tissue, i.e. cell suspension transplantation, tissue grafting and in vitro maturation, are presented. RESULTS obtained in humans are discussed in the light of lessons learned from animal studies.
  
  
  CONCLUSIONS
  Advances in reproductive technology have made fertility preservation a real possibility in young patients whose gonadal function is threatened by gonadotoxic therapies. The putative indications for such techniques, as well as their limitations according to disease, are outlined.
authors.affiliation: Université Catholique de Louvain, Dept. of Gynecology and Andrology, Av. Hippocrate, 10, B-1200 Brussels, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: Wyns
keywords: Fertility; chemotherapy; cryopreservation; immature testicular tissue; radiotherapy